# Replimune Group, Inc.: Form 8-K, filed Sep 16, 2026

- Company: [Replimune Group, Inc.](/companies/repl.md) (CIK 1737953)
- Form: 8-K
- Filed: 2026-09-16
- Accepted by EDGAR: Sep 16, 2026, 16:05 ET
- Period: 2026-09-15
- Accession: 0001104659-26-108243
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737953/000110465926108243/tm2625488d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737953/000110465926108243/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737953/000110465926108243/tm2625488d1_8k.htm

Filed Sep 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-108243. Last ingested by Listed: Oct 28, 2026, 07:26 ET. No prices; not investment advice.